These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1903077)

  • 1. Fluoxetine and fluvoxamine.
    Guimaraes FS
    Br J Hosp Med; 1991 Mar; 45(3):146, 149. PubMed ID: 1903077
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
    Schatzberg AF; Dessain E; O'Neil P; Katz DL; Cole JO
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):44S-49S. PubMed ID: 3123528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine as an antidepressant drug.
    Doogan DP
    Neuropharmacology; 1980 Dec; 19(12):1215-6. PubMed ID: 6777709
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluvoxamine (Faverin): another antidepressive drug.
    Drug Ther Bull; 1988 Feb; 26(3):11-2. PubMed ID: 3131096
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine.
    Jordan S; Kramer GL; Zukas PK; Moeller M; Petty F
    Synapse; 1994 Dec; 18(4):294-7. PubMed ID: 7886621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High performance liquid chromatographic determination of fluvoxamine in human plasma.
    Pommery J; Lhermitte M
    Biomed Chromatogr; 1989 Jul; 3(4):177-9. PubMed ID: 2511937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New horizons in drug therapy of depression].
    Sirota P; Kaspi N
    Harefuah; 1992 Jun; 122(11):712-6. PubMed ID: 1526564
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluvoxamine as an antiobsessional agent.
    Goodman WK; Price LH; Rasmussen SA; Heninger GR; Charney DS
    Psychopharmacol Bull; 1989; 25(1):31-5. PubMed ID: 2505302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvoxamine--a baseline study of clinical response, long term tolerance and safety in a general practice population.
    Martin AJ; Wakelin J
    Br J Clin Pract; 1986 Mar; 40(3):95-9. PubMed ID: 3085700
    [No Abstract]   [Full Text] [Related]  

  • 11. Apathy and indifference in patients on fluvoxamine and fluoxetine.
    Hoehn-Saric R; Lipsey JR; McLeod DR
    J Clin Psychopharmacol; 1990 Oct; 10(5):343-5. PubMed ID: 2124218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of antidepressant drugs on macrophage cytotoxic activity in rats.
    Belowski D; Kowalski J; Madej A; Herman ZS
    Pol J Pharmacol; 2004; 56(6):837-42. PubMed ID: 15662098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Belgian multicentre study of fluvoxamine in depressive outpatients.
    Brasseur R; Van Moffaert M; Mesotten F; Ansseau M; Uytdenhoef P; Bartholome F
    Acta Psychiatr Belg; 1985; 85(5):636-43. PubMed ID: 3937441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
    Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder.
    Mullin JM; Pandita-Gunawardena VR; Whitehead AM
    Br J Clin Pract; 1988 Feb; 42(2):51-5. PubMed ID: 3140864
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-HT reuptake inhibitors in healthy human subjects.
    Netter P
    Clin Neuropharmacol; 1986; 9 Suppl 4():162-4. PubMed ID: 3105878
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of drugs in the treatment of obsessive-compulsive disorders].
    den Boer JA; Westenberg HG
    Ned Tijdschr Geneeskd; 1990 Mar; 134(10):503-4. PubMed ID: 2107405
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19.
    Mahdi M; Hermán L; Réthelyi JM; Bálint BL
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin and cortisol increase after fluvoxamine.
    Demisch K; Demisch L; Bochnik HJ; Nickelsen T; Althoff PH; Schöffling K; Rieth R
    Br J Clin Pharmacol; 1986 Nov; 22(5):620-2. PubMed ID: 3098271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.